Radcliffe Capital Management, L.P. - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 61 filers reported holding IBERE PHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q1 2021$2,958,000300,0000.12%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders